Evergreen Youth Secrets
  • Health News
  • Health Care
  • Staying Healthy
  • Beauty Advices
  • Health News
  • Health Care
  • Staying Healthy
  • Beauty Advices
No Result
View All Result
Evergreen Youth Secrets
No Result
View All Result
Home Health Care

Medicare won’t cover anti-obesity GLP-1 drugs as Biden admin proposed

by
April 4, 2025
in Health Care
0
Medicare won’t cover anti-obesity GLP-1 drugs as Biden admin proposed

The Centers for Medicare and Medicaid Services (CMS) announced Friday it will not be finalizing a rule proposed by the Biden administration that would have allowed Medicare and Medicaid beneficiaries access to anti-obesity drugs such as the highly in-demand GLP-1 medications.

In November last year, the Biden administration proposed a new rule that would allow drugs like Wegovy and Zepbound to be covered by Medicare and Medicaid, expanding access for roughly 3.4 million Medicare users and about 4 million Medicaid enrollees.

But in a notice released Friday, the CMS said it would not be finalizing this proposed rule, providing no further details.

Medicare does cover GLP-1 drugs when prescribed for conditions like diabetes and heart disease, but legislation from 2003 prohibits Medicare from covering drugs for weight loss.

There is a bipartisan push in Congress to allow for anti-obesity drugs and services to be covered through a bill called the Treat and Reduce Obesity Act (TROA), but it failed to advance in the last Congress.

Under the Biden administration’s proposal, older and/or low-income Americans with a body mass index of 30 or higher would have qualified for coverage for the drugs.

Health and Human Services Secretary Robert F. Kennedy Jr. has criticized GLP-1 medications like Ozempic in the past, claiming in interviews that these drugs are being pushed onto Americans by foreign companies who don’t sell the same product in their home countries.

Kennedy has instead focused on lifestyle changes for combatting obesity, though he told CNBC last year that GLP-1s “have a place” in treating the disorder. Newly confirmed CMS Administrator Mehmet Oz has spoken favorably of GLP-1 drugs, previously saying on social media that the benefits offered by these medications are “massive.”

Previous Post

Texas measles outbreak approaches 500 cases 

Next Post

Ousted FDA vaccine director calls Kennedy’s start ‘very scary’

Next Post
Ousted FDA vaccine director calls Kennedy’s start ‘very scary’

Ousted FDA vaccine director calls Kennedy's start 'very scary'

Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.

    Popular News

    New Hampshire lawmakers give final approval to gender-affirming care ban 

    New Hampshire lawmakers give final approval to gender-affirming care ban 

    June 27, 2025
    FDA expanding COVID vaccine warnings over rare heart side effect

    FDA expanding COVID vaccine warnings over rare heart side effect

    June 27, 2025
    Supreme Court upholds HHS authority over ObamaCare preventative care task force

    Supreme Court upholds HHS authority over ObamaCare preventative care task force

    June 27, 2025

    Trending

    Drugmaker shares drop after RFK Jr. tapped to lead HHS

    Drugmaker shares drop after RFK Jr. tapped to lead HHS

    November 15, 2024
    RFK Jr. sworn in as nation’s Health secretary

    RFK Jr. sworn in as nation’s Health secretary

    February 13, 2025
    Pelosi: Supreme Court made ‘correct decision’ on abortion pill access

    Pelosi: Supreme Court made ‘correct decision’ on abortion pill access

    June 13, 2024
    Top HHS spokesman resigns amid clashes with key RFK Jr. aide

    Top HHS spokesman resigns amid clashes with key RFK Jr. aide

    March 4, 2025

    Recent News

    New Hampshire lawmakers give final approval to gender-affirming care ban 

    New Hampshire lawmakers give final approval to gender-affirming care ban 

    June 27, 2025
    FDA expanding COVID vaccine warnings over rare heart side effect

    FDA expanding COVID vaccine warnings over rare heart side effect

    June 27, 2025

    Popular News

    • New Hampshire lawmakers give final approval to gender-affirming care ban 
    • FDA expanding COVID vaccine warnings over rare heart side effect

    About Evergreen Youth Secrets

    • Contact us
    • Privacy Policy
    • Terms & Conditions
    • Email Whitelisting

    Copyright © 2025 Evergreenyouthsecrets.com. All Rights Reserved.

    No Result
    View All Result
    • Health News
    • Health Care
    • Staying Healthy
    • Beauty Advices

    Copyright © 2025 Evergreenyouthsecrets.com. All Rights Reserved.